View in EDS

Dovitinib in patients with gastrointestinal stromal tumour refractory and/or intolerant to imatinib.

Saved in:
Bibliographic Details
Title: Dovitinib in patients with gastrointestinal stromal tumour refractory and/or intolerant to imatinib.
Authors: Joensuu, Heikki1, Blay, Jean-Yves2, Comandone, Alessandro3, Martin-Broto, Javier4, Fumagalli, Elena5, Grignani, Giovanni6, Del Muro, Xavier Garcia7, Adenis, Antoine8, Valverde, Claudia9, Pousa, Antonio Lopez10, Bouché, Olivier11, Italiano, Antoine12, Bauer, Sebastian13, Barone, Carlo14, Weiss, Claudia15, Crippa, Stefania16, Camozzi, Maura16, Castellana, Ramon17, Le Cesne, Axel18, Bouché, Olivier11 (AUTHOR)
Source: British Journal of Cancer. 10/24/2017, Vol. 117 Issue 9, p1278-1285. 8p. 3 Charts, 3 Graphs.
Database: Academic Search Ultimate
Description
ISSN:00070920
DOI:10.1038/bjc.2017.290